A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2)

Clinical trial NCT00550017 · TERMINATED

Trial details

NCT number: NCT00550017
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2007-12-01
Primary completion: 2010-03-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.